Bionovate Technologies Corp

BIIOOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$775

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume62

Open$0.00

Beta9.91

Earnings Financials Revenue

Bionovate Technologies Corp (BIIO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BIIO · earnings · updated Jun 8, 2026

Latest Earnings

Q3 FY2021Report Date: Sep 30, 2021

EPS Actual

-$0.00

Revenue

—

Fiscal Period

Q3 FY2021

FY ends December

Report Date

Sep 30, 2021

After Market Close

BIIO reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.21

Rev. $0.66B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.21

Rev. Est.$0.66B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q3 FY2021	Sep 30, 2021	—	-$0.00	—	—	—	—
— Q2 FY2021	Jun 30, 2021	—	-$0.00	—	—	—	—
— Q1 FY2021	Mar 31, 2021	—	-$0.00	—	—	—	—
— Q4 FY2020	Dec 31, 2020	—	-$0.00	—	—	—	—
— Q3 FY2020	Sep 30, 2020	—	-$0.00	—	—	—	—
— Q2 FY2020	Jun 30, 2020	—	-$0.00	—	—	—	—
— Q1 FY2020	Mar 31, 2020	—	-$0.00	—	—	—	—
— Q4 FY2019	Dec 31, 2019	—	-$0.29	—	—	—	—

Q3 FY2021

Sep 30, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

Jun 30, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2021

Mar 31, 2021

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2020

Dec 31, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2020

Sep 30, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2020

Jun 30, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2020

Mar 31, 2020

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2019

Dec 31, 2019

EPS Actual

-$0.29

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for BIIO.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2021	Sep 30, 2021	—	$0.00	$0.00	+0.00%
— Q2 FY2021	Jun 30, 2021	—	$0.00	$0.00	+0.00%
— Q1 FY2021	Mar 31, 2021	—	$0.00	$0.00	-8.52%
— Q4 FY2020	Dec 31, 2020	—	$0.00	$0.00	+10.97%
— Q3 FY2020	Sep 30, 2020	—	$0.00	$0.00	-16.08%
— Q2 FY2020	Jun 30, 2020	—	$0.00	$0.00	+0.00%
— Q1 FY2020	Mar 31, 2020	—	$0.00	$0.00	+0.00%
— Q4 FY2019	Dec 31, 2019	—	$0.00	$0.00	-2.87%

Q3 FY2021+0.00%

Report Date

Sep 30, 2021

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q2 FY2021+0.00%

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q1 FY2021-8.52%

Report Date

Mar 31, 2021

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q4 FY2020+10.97%

Report Date

Dec 31, 2020

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q3 FY2020-16.08%

Report Date

Sep 30, 2020

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q2 FY2020+0.00%

Report Date

Jun 30, 2020

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q1 FY2020+0.00%

Report Date

Mar 31, 2020

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q4 FY2019-2.87%

Report Date

Dec 31, 2019

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Beat Rate0 / 8 quarters

Largest Move-16.08% (Q3 FY2020)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Bionovate Technologies Corp (BIIO) most recently reported earnings on September 30, 2021 for Q3 FY2021, posting EPS of $-0.00 (in line with the analyst consensus of —). The next BIIO earnings date is expected around September 1, 2026.

Each quarter, investors track BIIO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIIO revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BIIO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BIIO earnings · 4 questions

Bionovate Technologies Corp's next earnings report is expected around September 1, 2026. BIIO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIIO historically reports after market close (AMC).

BIIO earnings datewhen is BIIO earningsBIIO next earnings datewhen does BIIO report earningsBIIO earnings calendar

▸ Source: FMP · Bionovate Technologies Corp SEC filings · US GAAP · Bionovate Technologies Corp SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026